eGenesis

Post-transplantation immunosuppression has come a long way: the first immunosuppressive, azathioprine, was developed in the 1960s and had one-year survival rates of 50-60%. Calcineurin inhibitors came

Venture capital investment in biopharmaceuticals companies reached a new record in 2020 and in 2021 the pace of new financings remains robust with many large VC rounds. Venture capital firms also cont